Not really the case here. Shore is over 80% done unblinding now...

Not really the case here. Shore is over 80% done unblinding now isn’t reckless, it’s strategic.FDA’s allowed early unblinding before, especially when the trial’s nearly finished and there's solid Phase 2 data to back it. MST even said unblinding now probably makes sense.This isn’t cutting corners it’s figuring out if there’s something worth saving and a path forward.